News

First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion

by

MELBOURNE, Australia, June 18, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II study of the Company’s carbonic anhydrase- (CAIX)-targeting PET/CT[1] imaging agent TLX250-CDx (89Zr-DFO-girentuximab), exploring this potential target across a broad range of cancer indications. The STARBURST study (ClinicalTrials.gov Identifier: … Read more

Sling Therapeutics Presents Data Demonstrating Linsitinib Prevents Thyroid Eye Disease Progression in a Mouse Model at ENDO 2023

by

– Treatment with linsitinib in a clinically relevant mouse model demonstrated a significant reduction in autoimmune response and classical Thyroid Eye Disease (TED) symptoms, independent of TED severity – – Ongoing global Phase 2b LIDS clinical trial evaluating linsitinib for treatment of active, moderate to severe TED – ANN ARBOR, Mich., June 17, 2023 /PRNewswire/ — Sling … Read more

The ‘Penicillin’ of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug

by

– Professor Heungjeong Woo of Hallym University College of Medicine, announced the result of Xafty’s clinical study at Emerging Science Session of the American Society for Microbiology (ASM) Microbe 2023 – Dr. Jo White evaluated Xafty’s clinical results as “The birth of Penicillin of Antivirals” and “a groundbreaking achievement that suggests a solution to respiratory … Read more

The ‘Penicillin’ of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug

by

– Professor Heungjeong Woo of Hallym University College of Medicine, announced the result of Xafty’s clinical study at Emerging Science Session of the American Society for Microbiology (ASM) Microbe 2023 – Dr. Jo White evaluated Xafty’s clinical results as “The birth of Penicillin of Antivirals” and “a groundbreaking achievement that suggests a solution to respiratory … Read more

MUITO ALÉM DA ESTÉTICA: DESCUBRA OS BENEFÍCIOS PSICOLÓGICOS DA CIRURGIA PLÁSTICA

by

SÃO PAULO, 17 de junho de 2023 /PRNewswire/ — O desejo de conquistar a estética perfeita é uma tendência crescente na sociedade atual, impulsionada pela autenticidade e bem-estar individual. E neste contexto, a cirurgia plástica se destaca como uma opção para atingir os almejados padrões de beleza. É importante destacar um fato interessante sobre os … Read more

Molfix Bond with Love Secure Attachment Bond Program was Honored with The International CSR Excellence Awards in its 5th Year

by

Bond with Love Secure Attachment Bond Program of Molfix, which supports the happy and healthy development of babies and is a reliable companion of mothers with its innovative approach, was honored with “The International CSR Excellence Awards” LONDON, June 17, 2023 /PRNewswire/ — Molfix Bond with Love Secure Attachment Bond Program, developed by Molfix to improve … Read more

IASO Bio Receives FDA Approval of IND Application for IASO-782 for Treatment of Autoimmune Disease

by

The second product of IASO to receive IND approval from the FDA SHANGHAI and NANJING, China and SAN JOSE, Calif., June 17, 2023 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, today announced that the U.S. Food and Drug Administration (FDA) … Read more

Alta Acts in Response to Stunning Disclosures by Mallinckrodt and Foreshadowing of Bankruptcy Filing

by

NEW YORK, June 17, 2023 /PRNewswire/ — Alta Fundamental Advisers LLC (“Alta”) filed an SEC Schedule 13D earlier today in connection with investments in the ordinary shares of Mallinckrodt Plc (“Mallinckrodt” or the “Company”).  Alta is an institutional investment manager headquartered in New York, NY.   Alta’s Schedule 13D disclosed Alta’s issuance of a letter earlier … Read more

Alta Acts in Response to Stunning Disclosures by Mallinckrodt and Foreshadowing of Bankruptcy Filing

by

NEW YORK, June 16, 2023 /PRNewswire/ — Alta Fundamental Advisers LLC (“Alta”) filed an SEC Schedule 13D earlier today in connection with investments in the ordinary shares of Mallinckrodt Plc (“Mallinckrodt” or the “Company”).  Alta is an institutional investment manager headquartered in New York, NY.   Alta’s Schedule 13D disclosed Alta’s issuance of a letter earlier … Read more

Dental 3D Printing Devices Market size is set to grow by USD 1,588.84 million from 2022 to 2027, The cost efficiency and enhanced productivity of dental devices with 3D printing to drive the market growth

by

NEW YORK, June 16, 2023 /PRNewswire/ — The dental 3D printing devices market is set to grow by USD 1,588.84 million from 2022 to 2027 progressing at a CAGR of 20.5% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. … Read more